A multiple-center, non-randomized, open-label study to investigate the effect of various degrees of renal impairment on the pharmacokinetics of a single intravenous dose of RO7223280
Latest Information Update: 02 Feb 2024
At a glance
- Drugs Zosurabalpin (Primary)
- Indications Acinetobacter infections; Bacteraemia; Nosocomial pneumonia
- Focus Pharmacokinetics
- Sponsors Roche
Most Recent Events
- 04 Dec 2023 Status changed from active, no longer recruiting to completed.
- 21 Apr 2023 New trial record
- 17 Apr 2023 Status changed from not yet recruiting to recruiting.